Effects of substance P (SP) and selective tachykinin agonists on neurotransmission at guinea-pig intracardiac ganglia were studied in vitro. Voltage responses of neurons to superfused tachykinins and nerve stimulation were measured using intracellular microelectrodes. Predominant effects of SP (1 µM) were to cause slow depolarization and enable synaptic transmission at low intensities of nerve stimulation. Augmented response to nerve stimulation occurred with 29 of 40 intracardiac neurons (approx. 73%). SP inhibited synaptic transmission at 23% of intracardiac neurons but also caused slow depolarization. Activation of NK 3 receptors with 100 nM [MePhe 7 ]neurokinin B caused slow depolarization, enhanced the response of many intracardiac neurons to low intensity nerve stimulation or local application of acetylcholine, and triggered action potentials independent of other stimuli in 6 of 42 neurons. The NK 1 agonist [Sar 9 ,Met(O 2 ) 11 ]SP had similar actions but was less effective and did not trigger action potentials independently. Neither selective agonist inhibited cholinergic neurotransmission. We conclude that SP can function as a positive or negative neuromodulator at intracardiac ganglion cells, which could be either efferent neurons or interneurons. Potentiation occurs primarily through NK 3 receptors and may enable neuronal responses with less preganglionic nerve activity. Inhibition of neurotransmission by SP is most likely explained by the known blocking action of this peptide at ganglionic nicotine receptors.
Introduction
Many studies over the last several decades have established that the heart contains an extensive network of ganglia and nerve fibers that comprise the intrinsic cardiac nervous system (1 -3) . Cholinergic efferent neurons are major components of this system and are recognized for their inhibitory influence on chronotropic, dromotropic, and inotropic functions of the heart. There is also evidence that intracardiac ganglia contain interneurons, sensory neurons and noradrenergic efferent neurons, which adds to the anatomical and functional complexity of the system (1, 2, 4 -7) . All of these neuronal types (i.e., efferent, sensory, and interneuron) have been identified in guinea-pig intracardiac ganglia based on electrophysiological and morphological criteria (6, 7) . Most neurons in guinea-pig intracardiac ganglia can be labeled with antibodies to choline acetyltransferase, which is a marker of the cholinergic phenotype (3, 4, 8, 9) . However, many studies have shown that markers for one or more additional neurotransmitters (e.g., nitric oxide and neuropeptide Y) are present in subpopulations of these neurons (3, 4, 10) . Accordingly, the cholinergic phenotype may not dominate in some cells. Preganglionic vagal efferent neurons, however, are an important source of excitatory cholinergic input to the intracardiac ganglia, and a majority of neurons in guinea-pig intracardiac ganglia are surrounding by cholinergic nerve fibers (3, 11) . Intracardiac neurons also receive and integrate input from many other nerve fibers that utilize distinct neurotransmitters such as substance P (SP) (1 -3, 10, 12 -14) .
Studies from our laboratory have shown that SP can cause bradycardia when administered to isolated guineapig hearts (15, 16) or anesthetized vagotomized guinea pigs (17) . These negative chronotropic responses are blocked by atropine and amplified by pretreatment with a cholinesterase inhibitor, indicating that they are mediated by intracardiac cholinergic neurons. This conclusion is supported by work of other investigators who demonstrated that SP acts directly on intracardiac neurons to cause slow depolarization and increase neuronal excitability (18 -20) . Since this effect occurs with virtually all intracardiac neurons in whole mount preparations of guinea-pig atrial ganglia, it is likely that efferent neurons and interneurons are sensitive to SP. Moreover, local application of the peptide, by pressure ejection from a micropipette, causes some intracardiac neurons to fire bursts of action potentials that persist for several seconds (18 -22) . This direct stimulant effect of SP on intracardiac neurons provides an explanation for the negative chronotropic response that SP evokes in isolated hearts and anesthetized guinea pigs.
It has been proposed that SP affects intracardiac neurons primarily through activation of the NK 3 subtype of the tachykinin receptor (19, 20) . This conclusion was based on the relative sensitivity of intracardiac neurons to local microejection of selective agonists and the observation that NK 3 -receptor blockade with SR 142801 caused a substantial reduction in the amplitude of slow depolarization produced by bath application of SP. It remains possible, however, that NK 1 and NK 2 tachykinin receptors are present in the intracardiac ganglia because we have detected specific binding sites for [ 125 I]Bolton-Hunter labeled SP and [ 125 I]neurokinin A at this location in guinea pig heart by in vitro receptor autoradiography (15, 23) . Furthermore, some degree of bradycardia was evoked in isolated guinea-pig hearts by bolus administration of a selective agonist for each subtype of tachykinin receptor (24) .
Previous work from this laboratory demonstrated that SP can augment the fast excitatory response of most intracardiac neurons to microejection of acetylcholine (ACh) in whole mount preparations of guinea-pig atrial ganglionated nerve plexus (22) . There were, however, a small number of intracardiac neurons at which SP attenuated ACh evoked responses. Our primary goal in the present study was to determine if SP could also modulate physiological responses evoked by endogenous ACh. For these experiments, cholinergic neurotransmission was activated by stimulation of nerve bundles in whole mount preparations and responses of single neurons within ganglia were recorded using an intracellular microelectrode. We also used selective NK 1 -and NK 3 -receptor agonists ([Sar 9 ,Met(O 2 ) 11 ]SP and [MePhe 7 ]neurokinin B, respectively) to investigate the neuromodulatory influence of these tachykinin receptor subtypes at the intracardiac ganglia.
Materials and Methods

Experimental preparation
Male Hartley guinea pigs (250 -350 g, n = 59) were anesthetized by intraperitoneal injection of 60 mg / kg sodium pentobarbital. The heart was rapidly excised and placed into a Krebs buffer (composition: 121 mM NaCl, 25 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , 5.9 mM KCl, 8 mM dextrose, 1.2 mM MgCl 2 , 2.5 mM CaCl 2 ; equilibrated with 95% O 2 -5% CO 2 ; pH 7.4; 8 -10°C). The atria were removed, pinned to the Sylgard floor of a custom recording chamber (2.0 ml), and superfused (5 ml / min) continuously with oxygenated buffer at 10°C. Overlying atrial and vascular tissue were removed by dissection from the endocardial surface to reveal the ganglionated nerve plexus located in epicardial connective tissue and fat (4, 8 -10) . After completing the dissection, the preparation was allowed to equilibrate for about 1.5 h while the temperature was gradually increased. Conventional intracellular microelectrode recordings were made from intracardiac neurons with the temperature of the superfusate maintained at 34°C by a thermostatically controlled heater (Warner Instruments, Hamden, CT, USA).
Microelectrode recording
Intracellular recordings from neurons were made using high-impedance (70 -150 MΩ) borosilicate glass micropipettes filled with filtered 3 M KCl. Transmembrane potentials were recorded in a current clamp configuration using an Axoclamp-2B amplifier (Axon Instruments, Union City, CA, USA). After intracardiac neurons were impaled, they were allowed to stabilize for approx. 3 min before membrane properties were measured. Brief intracellular current pulses, triggered by a Grass S88 stimulator, were given through the recording electrode to characterize neurons (data not shown, see 22) . Intracellular current and potential signals were visualized using both analog and digital Tektronix oscilloscopes. Data were acquired and analyzed using a computer equipped with a Digidata 1200 analog-todigital converter and the pCLAMP software suite version 8.0 (Axon Instruments).
Nerve stimulation
Stimulus trains, triggered by a Grass S88 stimulator, were given through a concentric bipolar electrode (Frederick Hare, Bowdoinham, ME, USA) placed on a nerve bundle near the impaled neuron ( Fig. 1 ). Our stimulation protocol is illustrated in Fig. 2 . An estimate of the stimulation current required to reach threshold (I t ) was obtained by starting with low amplitude rectangular pulses and gradually increasing the current until an action potential was evoked from the recorded neurons or by starting with a higher amplitude pulse and decreasing the current until the stimulation no longer evoked an action potential. Both procedures were performed several times to refine our estimate of I t . Subthreshold and suprathreshold current levels were set at values slightly below and above the I t , respectively. Stimulus trains consisted of five pulses at the lower current followed by two pulses at the higher current ( Fig. 2: A  and B ). The lower current pulses did not trigger action potentials or fast excitatory postsynaptic potentials (EPSPs, Fig. 2B ). With the higher stimulation current, at least one of the two stimulation pulses in each set evoked an action potential ( Fig. 2 : B and C). This protocol was designed to detect both potentiation and inhibition of ganglionic neurotransmission by the tachykinins. Nerve stimuli were applied prior to, during, and after exposure to tachykinin agonists, which were added to the superfusion buffer. Stimulus current and intracellular potential signals were visualized and recorded as already described. The duration of each stimulation pulse was 2 ms in experiments with SP but was reduced to 0.2 ms in experiments with selective tachykinin agonists so response latency could be measured more accurately.
Materials
Acetylcholine chloride, atropine sulfate, and hexamethonium chloride were purchased from Sigma ( Nerve stimulation protocol and representative control responses evoked from impaled intracardiac neurons. Subthreshold (Sub) and suprathreshold (Supra) stimulation current levels were determined as described in Materials and Methods. A: Diagram depicting stimulation protocol. Trains of 5 subthreshold and 2 suprathreshold square pulses (2-ms duration) were delivered throughout the experiment at 10-to 15-s intervals. B: Typical responses to nerve stimulation are shown in this panel. Subthreshold pulses usually produced a stimulation artifact in the impaled neuron but did not cause a synaptically evoked response. Suprathreshold stimuli produced a stimulation artifact, and at least one of the two pulses evoked a single action potential. Only the upper portion of stimulation current traces are shown. Threshold current (It) was approx. 3.0 µA in this neuron. C: Infrequently, suprathreshold stimulation trains evoked an EPSP and an action potential as shown in this panel.
Preparation and storage of drugs
SP and [Sar 9 ,Met(O 2 ) 11 ]SP were dissolved in sterile saline while [MePhe 7 ]NKB was dissolved in dimethyl sulfoxide. Aliquots of stock solutions were stored at −80°C and discarded after one use. Atropine and hexamethonium were prepared fresh for each experiment.
Drug administration
It is known that ACh can activate muscarinic receptors on intracardiac neurons to produce slow depolarization and / or slow hyperpolarization of the cell membrane (25) . Therefore, atropine (1 µM) was added to the superfusion buffer to prevent these slow responses. SP, [Sar 9 ,Met(O 2 ) 11 ]SP, or [MePhe 7 ]NKB was added to the superfusion buffer and administered by bath application. The selective agonists were used at 100 nM and SP at 1 µM. Hexamethonium (100 µM) was added to the superfusion buffer at the end of each experiment to verify that responses to nerve stimulation were synaptically evoked and mediated by nicotinic receptors.
Influence of selective agonists on response to local application of ACh
These experiments used a protocol identical to that used previously to determine the effect of SP on responses to local application of ACh (22) . Briefly, ACh (10 mM) was administered by local pressure ejection from a glass micropipette (approx. 5 µm tip bore) using a Picospritzer (General Valve Corp., Fairfield, NJ, USA). For each neuron, we first determined a duration of ACh pulse that caused a reproducible fast depolarization below the threshold for firing. ACh pulses of this length of time (10 to 100 ms) were then applied repeatedly at 25-or 30-s intervals to evoke fast depolarization of consistent magnitude. Desensitization of nicotinic receptors did not occur under these conditions. While continuing such phasic applications of ACh, the preparation was superfused for 2 to 2.5 min with buffer containing 100 nM [Sar 9 ,Met(O 2 ) 11 ]SP or [MePhe 7 ]NKB. Applications of ACh continued during the washout period.
Data analysis and statistics
All data were obtained from neurons with stable resting membrane potentials more negative than −40 mV. For nerve stimulation experiments, it was also required that stimulation-evoked action potentials could be blocked by hexamethonium.
The influence of tachykinin agonists on cholinergic neurotransmission at intracardiac neurons was classified as potentiation, inhibition, or no effect. Classification was based on the change in response to nerve stimulation that occurred during a 10-min interval beginning at the time tachykinin was added to the bath. Potentiation was defined by the observation of at least one evoked action potential in each of three consecutive low current stimulus trains or in a total of five such trains. Inhibition was defined by the failure of high current stimuli to evoke action potentials during at least three consecutive stimulus trains or a total of at least five such trains. All other cases are reported as no effect. Depolarization of membrane potential in each group was expressed as the mean ± S.E.M. (n = number of neurons). An unpaired or paired t-test (2 tailed) was used to compare values for different groups. P<0.05 was considered significant.
Results
Hexamethonium blocks action potentials evoked by nerve stimulation
Nerve bundle stimulation evoked actions potentials from impaled intracardiac neurons with a latency of 3.1 ± 0.2 ms (n = 32, range of 1.2 to 5.6 ms). Bath application of hexamethonium caused reversible inhibition of these evoked action potentials ( Fig. 3 ). Blockade occurred approximately 2 min after beginning superfusion with 100 µM hexamethonium, and responses returned to normal within 5 min after stopping the antagonist. Increasing the stimulus current during exposure to hexamethonium failed to trigger action potentials but could trigger EPSPs (Fig. 3B ). These findings demonstrate that stimulation-evoked action potentials are mediated by endogenous ACh and therefore result from synaptic transmission. Hexamethonium blocked responses to nerve stimulation in all neurons included in this study.
SP can augment or inhibit responses to nerve stimulation
The predominant influence of SP (1 µM) was to facilitate synaptic transmission at lower intensities of nerve stimulation (Table 1 , Fig. 4 ). Prior to application of SP, these lower intensity stimuli did not evoke EPSPs or action potentials in any of the intracardiac neurons that were recorded ( Fig. 4A and left panel of 4B). During exposure to SP, a majority of stimuli at the same intensity triggered a single action potential from the recorded neurons ( Fig. 4A and middle panel of 4B). SP had only a minor influence on the response to stimulation at a higher current in the same neurons. One pulse in each pair of stimuli at the higher current occasionally failed to trigger an action potential under control conditions, whereas both stimuli consistently evoked a single action potential during treatment with SP ( Fig. 4B , left and middle panels). Multiple action potentials occurred in 6 out of 40 intracardiac neurons (15%) during superfusion with SP. For half of these neurons, the onset of firing did not coincide with nerve stimulation. In all cases (n = 40), the responses of intracardiac neurons to nerve stimulation returned to the control pattern after removal of SP ( Fig. 4A and right panel of 4B).
Augmentation of synaptic transmission by SP could be replicated over a long interval in the same neuron. This feature was identified in three neurons that had very stable impalements, which allowed recordings to be maintained for greater than one hour. For these cells, superfusion with SP was stopped after determining that the peptide potentiated neurotransmission at the lower of two stimulation intensities (standard protocol), and the cells were allowed to stabilize in the superfusion buffer solution for 30 min. The cells were then stimulated with only subthreshold pulse trains and superfused again with SP (1 µM). In each of these experiments, SP augmented the response to nerve stimulation (data not shown).
SP had a distinct inhibitory influence on synaptic transmission in a smaller number of intracardiac neurons (Table 1, Fig. 5 ). Prior to the application of SP, supra- threshold stimulus trains evoked action potentials in these neurons. Synaptically evoked action potentials were abolished in these cells for 1 to 5 min following superfusion with SP ( Fig. 5 ). Bath application of SP caused a slow membrane depolarization in all neurons tested (5.6 ± 0.5 mV, n = 40). There was no significant difference in the magnitude of this response between neurons where synaptic transmission was augmented or inhibited by SP (5.8 ± 0.7 mV, n = 29 versus 4.7 ± 0.7 mV, n = 9; P = 0.41).
NK 1 and NK 3 agonists induced slow depolarization of intracardiac neurons
Membrane voltage responses to separate bath applications of 100 nM [Sar 9 ,Met(O 2 ) 11 ]SP and [MePhe 7 ]NKB were measured alone and in conjunction with nerve stimulation or local applications of ACh. Both selective agonists caused slow membrane depolarization in all neurons tested (Fig. 6 ). The magnitude of this response was significantly greater for [MePhe 7 ]NKB than [Sar 9 ,Met(O 2 ) 11 ]SP whether tested in separate intracardiac neurons (6.0 ± 0.4 mV, n = 42 versus 3.3 ± 0.4 mV, n = 27; P<0.0001) or in the same cells (3.9 ± 0.4 mV versus 1.8 ± 0.5 mV, n = 4; P = 0.042). The effect of [Sar 9 ,Met(O 2 ) 11 ]SP on membrane potential was negligible when applied during blockade of voltagegated calcium channels with 200 µM CdCl 2 (0.7 ± 0.7 mV, n = 3), while the depolarizing action of [MePhe 7 ]NKB was unaffected by this treatment (6.6 ± 1.1 mV, n = 7). Application of the NK 3 -receptor agonist also evoked action potentials independent of nerve stimulation or pressure ejection of ACh in 6 of 42 intracardiac neurons (Fig. 6B ). There were no cases where [Sar 9 ,Met(O 2 ) 11 ]SP alone triggered firing of intracardiac neurons (n = 27). A: The upper trace shows a continuous transmembrane potential recording from an intracardiac neuron during lower and higher current stimulation of a nerve bundle that provides preganglionic parasympathetic input to the impaled cell. All of the higher current stimuli triggered action potentials prior to treatment with SP. During the time indicated by the bar, a small depolarization occurred, the amplitude of evoked action potentials was reduced, and some of the suprathreshold stimuli failed to evoke an action potential (not seen due to time scale). Shortly after that time, both stimuli in the suprathreshold trains failed to evoke an action potential. B: Selected portions from the same recording are shown at an expanded time scale to demonstrate details of the responses. Before exposure to SP (Control), subthreshold stimuli (3.2 µA) did not produce any synaptically evoked responses, while both of the suprathreshold stimuli (3.7 µA) evoked a single action potential. Synaptically evoked action potentials were inhibited for several min after exposure to SP (middle panel). Responses to nerve stimulation returned to the control level after wash-out of SP. Stimulation current traces are shown below each recording. Dotted lines cut off the lower portion (<2.5 µA) of current traces. 
Selective tachykinin agonists can augment responses to nerve stimulation and local application of ACh
Effects of the NK 1 and NK 3 agonists (100 nM) on the response of intracardiac neurons to nerve bundle stimulation were evaluated by the same method as used for SP. Lower intensities of nerve stimulation, which cause no postsynaptic response under control conditions, evoked action potentials in some intracardiac neurons during bath application of [Sar 9 ,Met(O 2 ) 11 ]SP or [MePhe 7 ]NKB (Fig. 7) . This effect occurred with 8 of 17 neurons (47%) for [Sar 9 ,Met(O 2 ) 11 ]SP and 10 of 17 neurons (59%) for [MePhe 7 ]NKB. The percentage of low current stimuli that caused action potentials did not differ statistically between peptides if all data were considered (37 ± 8% for NK 1 agonist versus 54 ± 10% for NK 3 agonist, P = 0.22). However, in four neurons where effects of both peptides were evaluated, more stimuli evoked action potentials in the presence of [MePhe 7 ]NKB compared to [Sar 9 ,Met(O 2 ) 11 ]SP (82 ± 2% versus 18 ± 3%, paired t-test; P = 0.006, n = 4). In contrast to SP, neither [Sar 9 ,Met(O 2 ) 11 ]SP nor [MePhe 7 ]NKB inhibited stimulation-evoked action potentials.
To evaluate postsynaptic interactions of the selective tachykinin agonists with ACh more directly, these peptides were added to the superfusion buffer (100 nM) during repeated local administration of ACh. ACh evoked fast depolarization was potentiated in 4 of 11 intracardiac neurons (36%) by [Sar 9 ,Met(O 2 ) 11 ]SP and in 15 of 20 neurons (75%) by [MePhe 7 ]NKB (Fig. 8) . The incidence of potentiation was significantly higher for [MePhe 7 ]NKB (P = 0.036, Chi-square test). Application of ACh evoked multiple action potentials in 7 of 15 neurons where [MePhe 7 ]NKB caused potentiation. The NK 3 agonist did not cause multiple action potential independent of ACh application in this group of neurons. The augmenting influence of [Sar 9 ,Met(O 2 ) 11 ]SP was manifest as only a single action potential per ACh pulse. The interaction of ACh and the selective agonists was further quantified by determining the percentage of ACh applications that evoked an action potential or multiple action potentials during a 10-min interval starting at the time when superfusion with tachykinin agonist was initiated. Although more ACh pulses triggered action potentials with [MePhe 7 ]NKB treatment compared to [Sar 9 ,Met(O 2 ) 11 ]SP (21.3 ± 6.3%, n = 15 versus 10.0 ± 3.5%, n = 4), this difference was not statistically significant (P = 0.38). Treatment with [Sar 9 ,Met(O 2 ) 11 ]SP or [MePhe 7 ]NKB did not inhibit the response of neurons to ACh.
Discussion
Previous reports have established that SP and selective tachykinin agonists can each affect the activity of canine intracardiac neurons when applied locally in anesthetized animals (26 -28) . The present study provides direct evidence that cholinergic neurotransmission within intracardiac ganglia of the guinea pig can be potentiated by treatment with the natural tachykinin SP or with each of two selective tachykinin agonists (i.e., [Sar 9 ,Met(O 2 ) 11 ]SP and [MePhe 7 ]NKB). Our results further demonstrate that SP can inhibit neurotransmission at a significant number of intracardiac neurons. Augmentation was manifest primarily as the generation of one action potential per nerve stimulus delivered at a current intensity that evoked no measurable response in the absence of tachykinins. Higher intensity stimuli, which evoked single action potentials under control conditions, generally did not cause multiple action potentials in the presence of tachykinins. Bath application of [MePhe 7 ]NKB also enhanced the response of most intracardiac neurons to local application of ACh, as reported previously for SP (22) , and evoked firing of multiple actions potentials in some neurons independent of nerve stimulation or application of ACh. Potentiation of responses to ACh occurred at a significantly lower incidence with [Sar 9 ,Met(O 2 ) 11 ]SP, and this tachykinin did not cause action potentials independent of other stimuli. Neither [Sar 9 ,Met(O 2 ) 11 ]SP nor [MePhe 7 ]NKB inhibited synaptic neurotransmission at intracardiac ganglia, suggesting that the inhibitory effects of SP are not mediated by NK 1 or NK 3 receptors.
Single pressure pulses of ACh commonly evoked more than one action potential during exposure to SP (22) , but nerve stimulation in the presence of SP usually evoked only one action potential per stimulus. For that reason, the augmenting influence of SP was more apparent when a lower intensity of nerve stimulation was used. In our previous study, pressure pulses of 10 mM ACh were 10 to 100 ms in duration, while nerve stimulation in this study used 2-ms square pulses. Thus, the length of ACh delivery and the total amount of ACh exposure were larger with pressure ejection than nerve stimulation. It is likely that these factors contributed to the more frequent triggering of multiple action potentials by pressure ejection of ACh compared to nerve stimulation during bath application of SP. This view is supported by the results obtained when [MePhe 7 ]NKB was employed in the present study. Local application of ACh in the presence of [MePhe 7 ]NKB triggered multiple action potentials in 7 out of 20 neurons evaluated (35%), while nerve stimulation under the same condition did not evoke multiple action potentials.
The incidence of inhibitory modulation by 1 µM SP was higher in the present study than observed when ACh was applied by pressure ejection (22) . Synaptically evoked responses were inhibited in 22% of the intracardiac neurons studied (9 out of 40), while the same concentration of SP attenuated the response to exogenous ACh in only 1 out of 18 cells (approx. 6%). There are several possible explanations for this discrepancy. First, this study focused on ganglia located adjacent to a large nerve bundle, while in the previous project, we recorded from neurons throughout the atrial ganglionated nerve plexus. Accordingly, it is possible that the neuronal populations were not identical. However, it is considered more likely that differences in the method of stimulation are involved. It is possible that SP might attenuate ganglionic transmission by inhibition of ACh release from preganglionic nerve terminals, but we are not aware of any studies establishing a precedent for this mechanism. Furthermore, our previous study established that micromolar concentrations of SP could attenuate the response of intracardiac neurons to exogenous ACh (22) . Thus, an alternative explanation for the present finding is that synaptically evoked responses may be more susceptible to inhibition at the postsynaptic site. Nerve stimulation releases limited amounts of ACh at discrete locations where rapid degradation by cholinesterase is likely to occur. This contrasts with pressure ejection, which bathes the neuron and its dendrites with ACh for the duration of the pressure pulse. Since responses evoked by nerve stimulation are clearly more physiological, the present findings suggest that inhibitory modulation by SP could be more prevalent and important than predicted based on its ability to affect responses to exogenous ACh. Experiments with several other nicotinic receptors systems (29 -32) , including rat intracardiac ganglia (31) , have provided convincing evidence that micromolar concentrations of SP inhibit responses to ACh by a mechanism that involves direct binding of the peptide to an allosteric site on the ganglion nicotinic receptor. This conclusion is supported by our results with [Sar 9 ,Met(O 2 ) 11 ]SP and [MePhe 7 ]NKB. Each of these peptides was used at a concentration sufficient to saturate their respective tachykinin receptor subtype (33) , yet neither of these selective tachykinin agonists inhibited the response of intracardiac neurons to nerve stimulation or local application of ACh.
The safety factor for cholinergic neurotransmission appears to be high at intracardiac neurons that we studied since small increases in stimulation current evoked action potentials abruptly instead of first producing graded EPSPs (34) . This finding is consistent with results reported for SAH cells of guinea-pig intracardiac ganglia (6) and for rat intracardiac neurons (35) . The absence of graded EPSPs precluded the use of paired pulse experiments (e.g., 36) to determine if SP might augment the response to nerve stimulation by enhancing the release of ACh. We attempted to resolve this dilemma by evaluating the effects of NK 1 and NK 3 tachykinin agonists. Previous electrophysiological experiments and functional studies with the isolated guinea-pig heart provided evidence that the NK 3 subtype is the dominant tachykinin receptor on intracardiac neurons (19, 20, 24) . In contrast, specific SP binding sites that we observed in intracardiac ganglia (15) might reflect the presence of presynaptic NK 1 receptors. Unfortunately, experiments with the selective agonists did not eliminate the possibility that tachykinins might affect release of ACh from preganglionic nerve terminals. In fact, both agonists augmented the response to nerve stimulation in the same manner as SP. Nevertheless, [MePhe 7 ]NKB caused a greater incidence and extent of potentiation compared to [Sar 9 ,Met(O 2 ) 11 ]SP in paired experiments. The NK 3 agonist was also more effective in augmenting the response of intracardiac neurons to local application of ACh. These findings support the proposed role of NK 3 receptors in mediating direct effects of SP on intracardiac neurons (20) .
The prominent role of NK 3 receptors in guinea-pig intracardiac ganglia may have a counterpart in the canine heart where there is autoradiographic and functional evidence that NK 3 receptors are present on intracardiac neurons (28) . Local administration of senktide increased the activity of most in situ right atrial neurons in that study and, in some cases, also affected cardiac function. Such an effect might be important in the human heart since SP-immunoreactive nerves are present in the intracardiac ganglia (37) .
The small depolarization of intracardiac neurons produced by [Sar 9 ,Met(O 2 ) 11 ]SP in our study contrasts with a previous report that found no effect (19) . This divergence could be due to different methods of peptide application, since [Sar 9 ,Met(O 2 ) 11 ]SP was applied by local pressure ejection (100 µM, 1 s) in the previous study and bath application for about 2 min was used in our experiments. It is possible that the small depolarization we observed with bath application of [Sar 9 ,Met(O 2 ) 11 ]SP might be an indirect effect due to release of another mediator from some site in the whole mount preparations (38, 39) . In accord with this hypothesis, [Sar 9 ,Met(O 2 ) 11 ]SP did not cause significant depolarization when voltage-gated calcium channels were blocked by 200 µM CdCl 2 , whereas [MePhe 7 ]NKB still evoked a large depolarization. In any event, our findings are consistent with the fact that [Sar 9 ,Met(O 2 ) 11 ]SP can evoke a small bradycardia in the isolated guinea-pig heart preparation (24) .
Discussion of our data ultimately requires consideration of the complexity of the intracardiac nervous system. A primary issue is the type of neuron studied since intracardiac ganglia contain efferent neurons, sensory neurons and interneurons. It is unlikely that we recorded from intrinsic sensory neurons since they are the least abundant type of neuron in guinea-pig intracardiac ganglia and receive little or no synaptic input (6, 7) . Most of the neurons that were studied had a short latency for generation of an action potential after nerve stimulation, and all of these responses were blocked by hexamethonium. These observations suggest that many of the neurons were activated by monosynaptic input from cholinergic nerve fibers. This characteristic would be expected for efferent neurons but might occur also with interneurons, since most neurons in guinea-pig intracardiac ganglia are surrounded by cholinergic nerve fibers (3, 11) . Accordingly, it remains possible that we recorded from some interneurons as well as efferent neurons. In a few cases, evoked action potentials occurred at longer latencies, which would be consistent with a multisynaptic mechanism. Such responses might involve interneurons in the same ganglion or local circuit neurons located in adjacent ganglia. We also observed that SP and [MePhe 7 ]NKB evoked multiple action potentials in some neurons independent of nerve stimulation. Such responses have been attributed to the direct stimulation of impaled neurons by tachykinin and the resulting increase in excitability (3, 18 -20, 40) . Nevertheless, we cannot eliminate the possibility that multineuronal processes within the intracardiac nervous system make some contribution to these responses.
In summary, our results demonstrate that SP can modulate cholinergic neurotransmission within intracardiac ganglia of guinea pigs by two distinct actions. The predominant effect of SP is to increase the response of intracardiac neurons to low intensity preganglionic nerve stimulation. This action can be attributed primarily to the stimulation of postsynaptic NK 3 receptors. Potentiation can occur also through activation of NK 1 receptors but this effect is smaller and probably occurs by an indirect mechanism. SP has the opposite effect at a smaller but significant population of intracardiac neurons where it inhibits neurotransmission. This effect does not involve NK 1 or NK 3 receptors and probably occurs through binding of SP to nicotinic receptors, as reported by other investigators (29 -32) . These findings are likely to have pathophysiological implications since SP is present in sensory nerves that innervate the intracardiac ganglia (3, 12, 13, 21, 37) .
